Bayer’s announcement that it is terminating the Monsanto brand as part of its takeover of the St. Louis agri-business company unfortunately won’t come close to ending controversies surrounding Monsanto. Can you say clean up on aisle four? One needs to look no further than the massive cancer trial that got underway in early July to understand the huge stakes Bayer is facing. The trial – in a nutshell – is whether or not California native DeWayne “Lee”Johnson developed non-Hodgkin’s lymphoma from exposure to Monsanto’s flagship product weedkiller Roundup. Johnson sprayed the chemical for years as part of his jobs serving as a goundskeeper for a school district in Benicia, California.
Despite Bayer’s $66 billion move – yeah with a B – to acquire Monsanto, there remains serious doubt among some advocates that the U.S. Department of Justice did not do enough to protect farmers and other stakeholders from escalating seed and chemical costs and the unappetizing possibility of fewer choices at the retail marketplace.
ByJohnathan Hettinger/Midwest Center for Investigative Reporting |
Over the past three years, these companies have on average paid their executives and directors more than $100 million, according to a Midwest Center for Investigative Reporting review of financial filings. The median was $94.5 million.
President Donald Trump’s pick for the country’s top antitrust position — and key regulator for the $66 billion deal between Bayer AG and Monsanto Co. — is expected to give his confirmation testimony on Wednesday.
ByEliván Martínez Mercado | Center for Investigative Journalism |
During Puerto Rico’s decade of fiscal crisis, when the Island became the top experimental center for genetically engineered seeds, the Government gave away to these seed multinationals over $526 million.
Hundreds of food and farm groups are calling on recently confirmed U.S. Attorney General Jeff Sessions to step in and block a wave of billion-dollar mega mergers sweeping across America’s agriculture industry.